Journal ArticleOPEN ACCESS

Candesartan - The next anti-amyloid drug?

Brain Communications (2022) 4(6)
DOI: 10.1093/braincomms/fcac293
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This scientific commentary refers to 'Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease' by Hajjar et al. (https://doi.org/10.1093/ braincomms/fcac270).

Cite

CITATION STYLE

APA

Yasar, S. (2022). Candesartan - The next anti-amyloid drug? Brain Communications, 4(6). https://doi.org/10.1093/braincomms/fcac293

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free